According to Pulmonx's latest financial reports and stock price the company's current price-to-sales ratio (TTM) is 5.30112. At the end of 2023 the company had a P/S ratio of 7.11.
Year | P/S ratio | Change |
---|---|---|
2023 | 7.11 | 21.02% |
2022 | 5.88 | -75.92% |
2021 | 24.4 | -67.58% |
2020 | 75.3 |
Company | P/S ratio | P/S ratio differencediff. | Country |
---|---|---|---|
Merit Medical MMSI | 3.56 | -32.86% | ๐บ๐ธ USA |
Inari Medical
NARI | 4.95 | -6.71% | ๐บ๐ธ USA |